BioMed Research International

Volume 2013 (2013), Article ID 693023, 14 pages

http://dx.doi.org/10.1155/2013/693023

Review Article

The Immune Interplay between the Host and the Pathogen in Aspergillus fumigatus Lung Infection

Helioswilton Sales-Campos, Ludmilla Tonani, Cristina Ribeiro Barros Cardoso, and Márcia Regina Von Zeska Kress

Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Avenida Do Café S/N, 14040-903 Ribeirão Preto, SP, Brazil

Received 2 May 2013; Accepted 14 June 2013

Academic Editor: Carlo Jose Freire de Oliveira

Copyright © 2013 Helioswilton Sales-Campos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The interplay between Aspergillus fumigatus and the host immune response in lung infection has been subject of studies over the last years due to its importance in immunocompromised patients. The multifactorial virulence factors of A. fumigatus are related to the fungus biological characteristics, for example, structure, ability to grow and adapt to high temperatures and stress conditions, besides capability of evading the immune system and causing damage to the host. In this context, the fungus recognition by the host innate immunity occurs when the pathogen disrupts the natural and chemical barriers followed by the activation of acquired immunity. It seems clear that a Th1 response has a protective role, whereas Th2 reactions are often associated with higher fungal burden, and Th17 response is still controversial. Furthermore, a fine regulation of the effector immunity is required to avoid excessive tissue damage associated with fungal clearance, and this role could be attributed to regulatory T cells. Finally, in this work we reviewed the aspects involved in the complex interplay between the host immune response and the pathogen virulence factors, highlighting the immunological issues and the importance of its better understanding to the development of novel therapeutic approaches for invasive lung aspergillosis.

1. Introduction

An infection due to an Aspergilli was first described in animals in 1815 when its presence was observed in the air sacs and lungs of a crown [1]. However, the first human case was only described almost 30 years later in Scotland, when the sputum of a patient was microscopically analyzed by Benett [2]. Those findings were followed by the description of bronchial and pulmonary aspergillosis in humans by Virchow [3] and the remark that this infection may occur coupled to other lung diseases such as tuberculosis [4]. Although the disease was already known by that time, the fungus Aspergillus fumigatus was only described by Fresenius in 1850 when air sacs and bronchi of a great bustard were analyzed [5]. Therefore, aspergillosis was firstly described as an opportunistic infection when an immunocompromised patient had a disseminated mycosis with the presence of A. fumigatus in lung and kidney, besides Candida in liver and spleen, or the concomitant presence of both fungi in other tissues [6].

Ubiquitous in nature and without geographic predilection, Aspergillus species are found in the air, food, water, soil, and decomposing vegetation where they play an essential role in recycling environment carbon and nitrogen. Inhalation of Aspergillus spp. conidia by immunocompetent individuals rarely has any adverse effect, since the conidia are efficiently eliminated by immune mechanisms. Thus, the isolation of A. fumigatus from respiratory secretions in normal hosts generally reflects colonization rather than infection [7–9]. In the last decades, with the advent of solid organ and bone marrow transplantation, the increased use of immunosuppressive drugs, and the epidemic infection with the human immunodeficiency virus (HIV), the disease caused by A. fumigatus has emerged as a severe infection in immunocompromised patients. Established infection in these patient groups has proven difficult to eradicate, and despite significant advances in antifungal therapy in recent years, overall mortality with invasive disease remains high [10]. The most frequent pathogenic agent of aspergillosis is A. fumigatus, followed by A. flavus and A. niger [11]. Among them, the first has some characteristics which may allow a greater adhesion to the airways before invasion such as its ability to bind to laminin [12], thus conferring an evolutionary advantage to A. fumigatus during infection over the others.

The incidence of invasive aspergillosis is increasing [13–16], and A. fumigatus causes approximately 90% of this disease [8]. Thus, the development of pulmonary aspergillosis, which involves severe pulmonary manifestations, relies on a series of predisposing aspects and on a complex interplay between both the host immune competence and the pathogen virulence factors.

2. Aspergillus fumigatus Virulence Factors

The virulence of Aspergillus fumigatus is multifactorial and is combined with both the immune status of the patient and the biological characteristics of the fungus. There is a high connection between them, as demonstrated by the differences in the activation of the innate immune system which depend on the Aspergillus spp. morphology, growth stage, environment sensing and species, representing a key factor in fungal pathogenicity [17]. Once the fungus conidia reached the host environment, which is a different condition found in their normal environment niche, it must continually adapt to survive. These adjustments are classified according to the process they are involved in, for example, thermotolerance, toxins, cell wall composition and conservation, resistance to the immune response, nutrient uptake, signaling, metabolism, and response to stress condition.

The decaying organic matter is the normal environment for A. fumigatus, which is subjected to a wide temperature variation as a consequence of intense microorganism activity. The ability to grow at 37°C is shared by all successful human pathogens and is a feature that has been shown to correlate with virulence potential. A. fumigatus can grow between 37 and 50°C and is therefore more resistant and has better thermotolerance than other Aspergillus species [18, 19]. The ribosomal biogenesis proteins encoded by crgA [20], α-mannosyltransferase (kre2/mnt1) [21], and the endoplasmic reticulum-transmembrane sensor encoded by ireA [22] are to date the proteins associated with thermotolerance growth and hypovirulence, when the respective genes were deleted from A. fumigatus genome.

The fungal cell wall of A. fumigatus represents the first point of contact with the hosts and plays an important role in the infection process. It is a polysaccharide-based three-dimensional network which is a physical protection and provides a dynamic structure that is continuously changing as a result of the modification of the culture conditions and environment stress. The cell wall is composed by (1,3) and (1,4)glucans, (1,3)glucans, chitins, and galactomannans [23]. A melanin layer and sialic acid are found in the conidia surface, and a hydrophobic component layer is present on both conidia and hyphae [24]. The skeleton pattern arrangement of the cell wall is composed by the (1,3)glucan branched with (1,6)glucan that is covalently bound to chitin and (1,3/1,4)glucan. Dectin-1, an innate immune receptor of the mammalian cell, recognizes the fungal cell wall pathogen-associated molecular patterns [25] and may initiate immune response against the fungus. Additionally, -glucan is present in almost all fungi and has been used for the diagnosis of invasive mycosis [26].

The most abundant polysaccharide in the A. fumigatus cell wall is (1,3)glucan and among the three (1,3)glucan synthases identified in the fungus genome, only ags3 mutant has shown virulence changes (hypervirulence) in an experimental mouse model of aspergillosis [27]. Seven chitin synthases encoding genes have been identified in A. fumigatus genome, among them four genes were assessed for virulence profile and only the chsG null mutant strain displayed hypovirulence phenotype [28]. The main exoantigens released by the fungus during tissue invasion are the galactomannans [9], which may activate the innate immune response away from the focus of the infection. In the cell wall the galactomannans are composed by a linear -mannan backbone and short chains of (1,5)galactofuranose residues [29]. Galactofuranose biosynthesis starts with the isomerization of UDP galactopyranose to UDP galactofuranose by UDP galactomutase encoded by the glfA gene. The absence of UDP galactomutase in A. fumigatus led to attenuated virulence in a mouse model of invasive aspergillosis [30].

Glycosyl phosphatidyl inositol (GPI) motif proteins anchored to the plasma membrane play important roles in the biosynthesis and organization of the fungal cell wall. Many proteins such as cell surface enzymes, receptors, and adhesion molecules are anchored to the cell membrane by the GPI anchor which in turn may transfer the cell-wall-related information across the cell membrane. In this context, the absence of glucanosyltransferase encoded by gel2 gene has been related to hypovirulence of A. fumigatus [31]. Another gene related to the virulence attenuation in A. fumigatus is Afpig-a, which encodes the catalytic subunit of a complex that catalyzes GPI anchor biosynthesis [32]. On the other hand, ecm33 gene, which encodes a GPI-anchored protein, plays an important role in maintaining fungal cell wall integrity, and the absence of this enzyme enhances the virulence of the fungus [33].

Signal transduction pathways play a critical role in the biology of all living cells contributing to the integration of environmental cues into appropriate cellular activities. Proteins that participate in the signal transduction such as the G-proteins, MAP kinases, adenylate cyclases, and protein kinases (PKA) have been associated with virulence control and development of fungal pathogens [34]. The cyclic adenosine monophosphate (cAMP) PKA dependent is the central component of the cAMP signaling cascade. PKA is a serine/threonine kinase composed by the catalytic subunit pkaC1 and the regulatory subunit pkaR. The central messenger of the signal transduction pathway is cAMP, produced by the adenylate cyclase, which is regulated by GpaB, a G-protein- subunit. The malfunction of the PKA pathway by the disruption of gpaB, pkaC1 [35], or pkaR [36] in A. fumigatus leads to virulence attenuation in mice. cAMP, the second messenger molecule, is produced after perception of an extracellular signal by the G-protein-coupled receptor (GPCR). GprC and GprD in A. fumigatus are GPCRs and important for fungal metabolism regulation, conidia germination, and hyphae elongation and branching. Furthermore, these receptors regulate resistance towards environmental stress caused by reactive oxygen intermediates and elevated temperatures. They also play a role during the infection process, as the mutant strains were attenuated in virulence. Additionally a connection of the receptors with calcineurin-mediated signal transduction [37] is proposed.

Calcium-dependent signaling mechanisms in fungi have been associated with the regulation of wide variety responses to stress including survival in the host environment and resistance to antifungal drugs [38]. Calcium enters the cell via plasma membrane channels in response to external stress and activates the calcium-binding protein calmodulin that in turn activates calcineurin, a protein phosphatase responsible for the stimulation of downstream target genes. In fungi calcineurin regulates localization and activity of Crz1p-like transcription factor [39, 40]. The deletion of the catalytic subunit of calcineurin, calA/cnaA [41, 42] and crzA [43, 44] in A. fumigatus, led to significant defects in conidial germination, polarized hypha growth, cell wall structure, and attenuation of mortality rate in a neutropenic murine model of invasive pulmonary aspergillosis. Calcineurin and Ras proteins have been implicated in parallel activity in the regulation of hyphal and cell wall formation [45]. Ras are small monomeric GTPases proteins that act as molecular switcher which transduce signals from outside of the cell to the signal pathways inside the cell. Three Ras proteins have been studied in A. fumigatus, RasA, RasB, and RhbA. RasA is critical for polarized morphogenesis and cell wall stability [46] and RasB have been implicated in the control signaling modules important to the directional growth of fungal hyphae [47]. On the other hand, RhbA is implicated on nitrogen-dependent nutrient sensing and acquisition [48]. The deletion of Ras proteins encoding genes, ΔrasA, ΔrasB, and ΔrhbA leads to A. fumigatus virulence decrease in murine model of invasive pulmonary aspergillosis [46–48].

The genome of A. fumigatus conidia is protected from enzymatic lysis, ultraviolet light and oxidation by a gray-green melanin layer adhered to the cell wall [49]. The transcription of the essential genes for the biosynthesis of both types of melanins, pyomelanin and dihydroxinaphthalene (DHN)-melanin, are detected during infection and also protect A. fumigatus against reactive oxygen species (ROS), which are important compounds from the host innate immunity against pathogens [50, 51]. Pyomelanin production is associated with the tyrosine degradation pathway by the oxidative polymerization of an intermediate of the pathway, the homogentisic acid (HGA) [50]. In response to human neutrophils [52] and dendritic cells [53], four genes of the tyrosine degradation pathway (hppD, hmgX, hmgA, and fahA) showed increased transcription, leading to believe that pyomelanin is involved in fungal survival by escaping from the host immune system. DHN-melanin production starts by the polyketide synthase Alb1/PksP. The presence of a functional alb1/pksP gene in A. fumigatus conidia is associated with an inhibition of phagolysosome fusion in human monocyte-derived macrophages [54], which can justify the virulence attenuation of the pigmentless alb1/pksP null mutant in murine infection model [55–57].

Macrophages and polymorphonuclear cells such as neutrophils produce reactive oxygen species (ROS) as defense mechanism against the fungal conidia and hyphae, respectively. On the other side, the fungus produces specific enzymes for ROS detoxification. One category of ROS detoxification proteins is the catalases peroxidases, Cat1/CatB and Cat2/KatG, produced by the fungus mycelia. The null mutant of each gene in A. fumigatus led to mycelial hydrogen peroxide sensitivity and virulence reduction in the lungs of immunosuppressed rats [58]. Additionally, the cyclic AMP-dependent protein kinase (PKA), a well-known regulator of stress response in eukaryotes, contributes to the growth, germination, ROS response, and the virulence response of A. fumigatus [36]. Another group of genes related to oxidative stress response are the fatty acid oxygenases ppoA, ppoB, and ppoC, which are similar in sequence to specific mammalian prostaglandin synthases, the cyclooxygenases. The fatty acid oxygenase encoding genes in A. fumigatus were tested for virulence, and the triple mutant strain was found to be hypervirulent in an invasive murine model, showing increased tolerance to hydrogen peroxide [59]. Finally, the null mutant of a nonribosomal peptide synthetase gene, pes1 showed a significant reduction in virulence in the Galleria mellonella model system and an increased sensitivity to oxidative stress in culture and during neutrophil-mediated phagocytosis [60].

In fungi, such as A. fumigatus, transcription factors represent an important genetic component for the establishment of an infection by the activation or repression of different mechanisms that regulate virulence and pathogenicity. The putative C₂H₂ transcription factor DvrA was identified in A. fumigatus as a negative regulator of host cell damage and stimulation as well as virulence during invasive pulmonary disease. The deletion of this gene led to the stimulation of CCL20, interleukin-8, and the tumor necrosis factor mRNA expression in a pulmonary epithelial cell line. Additionally, there were increased virulence and pulmonary inflammatory response in neutropenic mouse model of invasive pulmonary aspergillosis [61]. In a similar way, the deletion of the transcription factor Ace2 in A. fumigatus induced accelerated mortality, greater pulmonary fungal burden, and increased pulmonary inflammatory responses in nonneutropenic mice immunosuppressed with cortisone acetate. The phenotype of Δace2 mutant in A. fumigatus was characterized by dysmorphic conidiophores, reduced conidia production, and abnormal conidial cell wall architecture, besides the reduced mRNA expression of ppoC, ecm33, and ags3. The null mutants of these genes have shown increased virulence in mice, as well as other phenotypic similarities to the Δace2 mutant [62].

The filamentous fungi are well known microorganisms producers of secondary metabolites [63]. It is believed that the production of these secondary metabolites is linked to the protection of the fungus against the host [64]. In fungi, the genes required for the biosynthesis of secondary metabolites are clustered [65]. The gene laeA encodes the transcription factor methyltransferase which is the global regulator of the secondary metabolite clusters in A. fumigatus [66, 67]. The deletion of laeA in this fungus reduces the secondary metabolite production, including gliotoxin and reduces the virulence in a murine neutropenic model [68]. Gliotoxin is a member of the epipolythiodioxopiperazine class of toxins and is both the major and the most potent toxin produced by A. fumigatus. This fungus maintains its normal virulence after deletion of the gene that encodes a nonribosomal peptide synthase of the gliotoxin biosynthetic cluster, gliP, in neutropenic mice immunosuppressed with a combination of cyclophosphamide and corticosteroids. However, the fungus becomes hypovirulent when the mice are immunosuppressed with corticosteroids alone [69]. In the same way, the deletion of the gene pld which encodes Phospholipase D attenuates the virulence in mice immunosupressed with hydrocortisone acetate but not with cyclophosphamide [70]. Phospholipase D modulates the internalization of A. fumigatus conidia into host epithelial cells. Phospholipases cleave host phospholipids, resulting in membrane destabilization and host cell penetration [71].

Fungal amino acid biosynthesis is vital to the pathogen metabolism and a conserved transduction cascade which links the environmental stimuli to amino acid homeostasis is the cross-pathway control (CPC) system. cpcA gene in A. fumigatus encodes the transcriptional activator of the CPC system of amino acid biosynthesis and the cpcA null mutant displayed attenuated virulence in a murine model of pulmonary aspergillosis [72].

The transcription factor SebA was demonstrated in A. fumigatus to be involved in the response to poor nutritional condition, osmotic, oxidative, and heat shock stress. Additionally, in the absence of the gene sebA, there is attenuated virulence of A. fumigatus in the neutropenic murine model of invasive pulmonary aspergillosis and decreased viability of the fungus during alveolar macrophages phagocytosis [73].

The fungal virulence traits are determined by regulatory elements which control their development and asexual reproduction. MedA is a developmentally regulated protein initially identified in the related model organism A. nidulans [74]. The A. fumigatus medA null mutant produced conidiophores with impaired phialide and conidia formation, impaired biofilm formation on inorganic substrate, and pulmonary epithelial cell interaction abnormalities such as decreased adherence, damage, and stimulation of cytokine production. MedA is required for normal virulence in an invertebrate and in a murine model of invasive aspergillosis [75].

An essential precondition for the beginning and manifestation of an infection is the nutrient uptake availability at the site of the infection. The pathogenic fungi are well adapted to deal with competitors for nutrients and are adapted to the fast environmental shift [76]. A. fumigatus is able to uptake nutrients from destruction of the host tissue by its secreted proteases. The main A. fumigatus secreted protease is the alkaline serine protease Alp1/asp f 13, which had been shown to be abundant in infected lung tissue and able to degrade some complement components (C3b, C4b, and C5) [77].

In living cells tissue, the iron and zinc availability are in low levels, enough to restrict the growth of pathogens. The transcriptional activator ZafA from A. fumigatus regulates the zinc homeostasis and is essential for the pathogenicity and virulence of the fungi, once the zafA null mutant is avirulent in a cortisone acetate-immunosuppressed mice [78].

Among micronutrients of the environment, iron is an essential nutrient for Aspergillus sp. and a key component of several enzymes that participates in a variety of cellular processes [79]. The iron sequestration is an important factor in host defense against invading fungi, since it prevents in vivo fungal development [80]. Low-molecular mass iron-specific chelators called siderophores are employed by the fungus to regulate iron load, which are of great importance in fungal virulence [81]. A. fumigatus can acquire iron by two different ways, by reductive iron assimilation and by siderophore-assisted iron uptake. The protein FtrA is a high affinity iron permease which belongs to the reductive mechanism for iron assimilation. The inactivation of ftrA gene in A. fumigatus does not change the virulence in a murine infection model. By contrast, the low virulence after the inactivation of siderophore-assisted iron uptake components, sidC, sidD, sidF, and sidG indicates that siderophore biosynthesis but not reductive iron assimilation mechanism is essential for A. fumigatus virulence [82–84]. Among the Aspergillus species, the acquisition of iron under depleted condition of this compound is controlled by the proteins SreA and HapX [85, 86]. AcuM is the transcription factor involved in the suppression of sreA and induction of hapX to stimulate expression of genes involved in both reductive iron assimilation and siderophore-mediated iron uptake, besides gluconeogenesis regulation. A. fumigatus acuM mutant had reduced iron incorporation, decreased extracellular siderophore production, impaired capacity to grow under iron-limited conditions, and decreased virulence in Galleria melanogaster larvae model, as well as in murine models of hematogenously disseminated and invasive pulmonary aspergillosis [87]. Curiously, sreA null mutant is as virulent as an A. fumigatus wild-type strain, but HapX-deficiency causes significant attenuation of virulence in a murine model of aspergillosis [86].

Iron also influences processes such as ergosterol biosynthesis, azole drug resistance, hypoxia adaptation, and the interaction with the host immune cells [88–90]. The iron availability in eukaryotes and cellular response to low oxygen are intimately related [91].

In an infection, A. fumigatus is exposed to active changes in the oxygen concentration, once the quantity of oxygen at the site of infection is low due to the inflammatory response. SrbA, related to the sterol regulatory element-binding protein, is critical for coordinating genes involved in iron acquisition and ergosterol biosynthesis under hypoxia and low iron conditions found at the site of the human infection [88]. A. fumigatus srbA null mutant is incapable of growth in a hypoxic environment and consequently is ineffective in causing disease in a murine model of invasive pulmonary aspergillosis [92]. Mitochondrial respiration is active in hypoxia and critical for fungal pathogenesis. The deletion of the cytochrome C (cycA) which is involved in mitochondrial respiration in A. fumigatus led to significant impaired conidia germination, growth in normoxia/hypoxia, and the fungus displayed attenuated virulence in murine model of invasive pulmonary aspergillosis [93].

In summary, fungi are versatile organisms able to adapt to diverse environmental conditions in order to grow and survive. In a hostile environment like the human body, A. fumigatus must evade intricate host defenses with the help of a growing number of virulence factors that are continuously being described. These molecules, which are expressed and secreted by fungus, enable host colonization, and promote immunoevasion, immunosuppression, and pathogen nutrition. On the other hand, the host immune response status is the key point that defines the progression of a disease, like the pulmonary invasive aspergillosis.

3. Host Response to Aspergillus fumigatus

Clinical manifestations of aspergillosis are determined by the host’s immune response against the fungi and have been classically divided into allergic, saprophytic, and invasive forms [94]. In this context, in atopic individuals, the fungus triggers immune-mediated phenomena such as allergic rhinitis, asthma, and allergic bronchopulmonary aspergillosis (ABPA) [95], involving the upper and lower respiratory tracts. Allergic bronchopulmonary aspergillosis affects 1-2% of asthmatic subjects and 7–9% of cystic fibrosis patients [96, 97]. This pathology is characterized by a T helper 2 (Th2) lymphocyte response, eosinophilia, and increased serum IgE levels [98, 99]. However, in patients with preexisting cavitary lesions as a result of diseases such as tuberculosis, sarcoidosis, bronchiectasis, or cavitary neoplasia [100], growth of the fungus leads to saprophytic aspergilloma [101], which is a saprophytic form of aspergillosis [102]. In immunocompromised individuals, some conidia germinate in the lungs as hyphae, the invasive form of the fungus, causing serious angioinvasive infection, often fatal, known as invasive pulmonary aspergillosis [103, 104].

3.1. Innate Immune Response

Aspergillus species are moulds widespread in the world, and the most common source of infection is the inhalation of spores (conidia) into the lungs and sinuses [105]. Due to the small size of A. fumigatus conidia (3–5 μm) and the presence of a hydrophobic protein-coat layer which underlies immunologically active polysaccharides and consequently protect them from host defense, the spores may penetrate deeply into the respiratory tract where they find appropriate conditions to develop [11, 106, 107]. Although A. fumigatus has not been described as an intracellular pathogen, the in vitro ability of its conidia to bind to respiratory epithelium cells, to be phagocytosed, and to survive into acid organelles of these cells was already shown [97, 108] suggesting that A. fumigatus may use epithelium cells to escape from phagocytes. Besides, the ability of this fungus to cause damage to epithelial cells by reducing the beating of cilia from ciliated cells and thus impairing an important physical barrier which protects host against fungal invasion was already shown in an ex vivo model using human cells. This detrimental effect was probably due to the production of mycotoxins such as gliotoxin, fumagillin, and helvolic acid [109]. Other findings showed that respiratory cells may be activated by double-stranded RNA from A. fumigatus conidia and initiate an immune response via IFN- production [110].

The recognition of A. fumigatus constituents by innate immunity and subsequent signaling is related to pattern recognition receptors (PRRs), which include C-type lectin and toll-like receptor (TLR) families that recognize pathogen-associated molecular patterns (PAMPs) like fungal wall components [111, 112]. As described before, C-type lectin, such as dectin-1, is a receptor for -glucans, one of the fungus wall compounds and one of the major innate receptors for protection against A. fumigatus. Dectin-1 deficient mice are more susceptible to fungal infection when compared to control group, as demonstrated in a study where the deficient mice showed an impaired production of inflammatory cytokines and chemokines such as IL-1, TNF-, CCL3, CCL4, and CXCL1, leading to insufficient lung neutrophils recruitment and reactive oxygen species (ROS) production besides uncontrolled growth of A. fumigatus in lungs. In this study it was also observed an impaired capability of macrophages to produce proinflammatory mediators in response to fungus infection in the absence of dectin-1 [112]. This receptor, which is also a structural component of the corneal epithelial cells, has its expression increased early after Aspergillus fumigatus infection of the cornea of rats [113].

The role of TLR family in the host defense against A. fumigatus infection was already described too. These receptors are able to activate the antifungal properties of many innate leukocytes such as macrophages and polymorphonuclear (PMN) cells. Netea et al. demonstrated that TLR2 is related to the recognition of yet unidentified ligands of conidia and hyphae, whereas TLR4 was only associated with the recognition of conidia ligands [114]. The activation of TLR2 by A. fumigatus was observed with the formation of the heterodimers TLR2/6 in mice and TLR2/1 both in human and mice cells in vitro [115]. The activation of TLR4 led to the oxidative pathways with azurophil and myeloperoxidase granules release [116]. Rubino et al. using an A. fumigatus strain (rodA CBS 144-89) deficient in a protein (Rod A), which prevents innate immune recognition, demonstrated both in human and murine cells the role of TLR2 and TLR4 in the recognition of this fungus by innate immune cells beyond the dependence of TLR1 (in human and mice cells) and TLR6 (in murine cells) for recognition [115]. Therefore, to evaluate the role of TLR in the response against A. fumigatus, bone marrow-derived macrophages from wild-type, TLR1, TLR2, TLR3, TLR4, and TLR6 knockout mice, were coincubated with the fungus. A reduced production of proinflammatory cytokines and chemokines such as IL-12p40, CXCL2, IL-6, and TNF-α from TLR1 deficient macrophages was observed, and this production was almost abolished in TLR2, TLR4, and TLR6 knockout cells but not in wild-type or TLR3 deficient macrophages, showing the importance of TLR1, TLR2, TLR4 and TLR6 in the fungal recognition and clearance. Moreover, to evaluate the role of TLR in human cells, Rubino et al. also used HEK293T cells transiently transfected with vectors of human TLR1, TLR2, or TLR6 and demonstrated that only in the presence of human TLR1 and TLR2 A. fumigatus was recognized, and there was activation of the inflammatory transcription factor NF-κB. Furthermore, the importance of TLR6 was reinforced in a study conducted with mice deficient in this receptor, in a model of A. fumigatus allergic induced asthma. In this work it was observed that in the absence of TLR6, there was a lower production of IL-23 and Th17 response, which resulted in exacerbated asthma response [117]. Regarding TLR4, when this receptor (and coreceptor CD14) was blocked with specific monoclonal antibodies in human monocytes in vitro (using the concentrations of 1, 3, or 10 μg/mL), an inhibition between 35–70% of TNF- releasing was observed especially when the highest concentration was used, thus highlighting its relevance on innate immune recognition of A. fumigatus [118]. On the other hand, triggering TLR2 induced oxidative pathways in PMN with the release of gelatinases and inflammatory cytokines [116]. To note, gelatinases that are extracellular matrix destructive enzymes [119] are associated with PMN migration during inflammation and are mobilized more readily than other molecules such as lactoferrin and azurophil granules [120]. In ABPA, caused by A. fumigatus, an increased inflammatory infiltrate containing neutrophils is found as well as elevated levels of the gelatinase MMP-9 and the cytokine IL-8, compared to asthma patients and controls. Moreover, IL-8 correlated with neutrophils and MMP-9 in the sputum, suggesting that the influx of neutrophils modulated by this cytokine may lead to a putative MMP-9-mediated tissue damage in the lungs [121]. Moreover, triggering of TLR3 were attributed to A. fumigatus conidia double-stranded RNA [110, 122], leading to contrasting results when compared to the study of Rubino et al. [115]. The opposite responses generated by TLR3 activation throughout the different studies were probably due to the strains used in them, besides different cellular and activation contexts. Therefore, such divergent results may be the consequence of diverse experimental conditions used by the authors of the studies. In addition, TLR9 activation was related to unmethylated CpG motifs present on the fungus DNA [123]. Thus, the importance of TLR seems clear, especially, TLR1, TLR2, TLR3, TLR4, TLR6, TLR9, and C-type lectin such as dectin-1 on A. fumigatus recognition by innate immune cells. Furthermore, MyD88, which is a molecule that mediates signaling downstream activation of most of TLRs mediates fungal clearance, inflammation, and tissue injury early after pulmonary infection with A. fumigatus [124].

Nucleotide-binding oligomerization domain (NOD) proteins (NOD1 e NOD2) are a subset of PRRs that recognize intracellular pathogens containing molecular patterns such as peptidoglycan. Therefore, NOD2 recognizes bacterial muramyl dipeptide (MDP) both from gram-positive and gram-negative bacteria [125], and its importance on immune response in different organs such as intestine [126] and lungs [127] was also observed. After the peptidoglycan detection the NOD proteins recruit the downstream adaptor molecule RIP2 hence activating proinflammatory pathways such as NF-B and mitogen-activated protein (MAP) kinases such as p38, ERK, and JNK [128]. NOD2 is also expressed by a human corneal epithelial cell line, especially after activation with A. fumigatus conidia, which then triggers the production of proinflammatory cytokines such as TNF- and IL-8 through the NF-B pathway [129]. Similarly, the stimulation of a macrophage cell line with A. fumigatus conidia resulted in significantly increased expression of NOD2, RIP2 and NF-B with the production of proinflammatory cytokines in a NOD2-dependent manner [130]. Therefore, this initial innate detection of A. fumigatus triggers important events for fungal control and clearance such as the production of inflammatory mediators, recruitment, and activation of immune cells.

The recognition of fungal cell wall compounds through PRRs is the beginning of the immune response, and the first components of defense against Aspergillus spp. in the alveoli are the alveolar macrophages (Figure 1), which phagocyte dormant or swollen spores, killing only swollen spores, especially due to the capability of lung resident macrophages to produce ROS [131]. Accordingly, Ibrahim-Granet et al., using murine and human alveolar macrophages, demonstrated that the activity of phosphatidylinositol (PI) 3-kinase during the initial steps of phagocytosis is required to properly kill spores in addition to the acidification of phagolysosome [132].

Figure 1: Summary of Aspergillus fumigatus and host immune system interplay. The lung pulmonary epithelium is magnified, and the immune response against fungal invasion is demonstrated. First, fungal components are recognized through pathogen recognition receptors (PRRs) which led to the activation of the innate immune response, depicted by macrophages, dendritic cells, natural killer cells, and neutrophils. The role of neutrophils during fungal infection is also represented by formation of neutrophils extracellular traps (NETs). The innate immunity triggers the development of an acquired immune response in the lung draining lymph nodes, which may induce the differentiation of Th1, Th2, or Th17 cell phenotypes depending on the specific stimuli and cytokine milieu, which also accounts with the presence of cytotoxic CD8 T cells against the fungus. These effector antifungal responses may also be modulated by the action of regulatory T cells (Tregs) to avoid excessive tissue damage.

Although macrophages were described for many years as the main responsible for A. fumigatus clearance [133], human and murine neutrophils (Figure 1) also seem to be essential to a successful response against this fungus, due to their ability to form NETs (neutrophil extracellular traps) or inhibit the growth and formation of both spores and hyphae [134, 135]. This fungal control by NETs occurs by the ability of neutrophils to reduce the polar germ tube growth coupled to the presence of calprotectin which may mediate the chelation of Zn⁺² ions. Moreover, the importance of formation of NETs to control fungal infection was reinforced in different studies using cells from patients with chronic granulomatous disease, which is a rare inherited disorder where neutrophils have a defect on ROS production, thus leading to increased susceptibility to bacterial or fungal infections [136, 137]. To note, the formation of NETs was first described in bacterial infection, as a property of innate immune cells to prevent microorganisms spreading due to a high local concentration of DNA coupled to a set of cytoplasmatic and granular proteins such as histones, elastase, and calprotectin, thus enhancing the capability of immune system to control infections [138–140]. To reinforce the importance of neutrophils in the control of A. fumigatus, Mircescu et al. observed, after depletion of alveolar macrophages or neutrophils, that mice infected with A. fumigatus had a greater presence of invasive fungus hyphae only when neutrophils were depleted when compared to the macrophages depleted group [141]. Despite the formation of NETs, neutrophils may also act against A. fumigatus infection through the production of ROS, as described by Sugui et al. who observed an up-regulation of catalases, superoxide dismutase, and thioredoxin reductase in the phagolysosome in an ex vivo model using human neutrophils [142]. Moreover, fungus phagocytosis by neutrophils led to a shift on fungus metabolism resembling a state observed under glucose limitation, suggesting that neutrophils may create nutrient limiting conditions to facilitate fungal killing [142].

Despite the importance of macrophages and neutrophils as the first barrier to control A. fumigatus infection, the role of other innate immune cells cannot be discarded. The ability of monocytes to phagocyte and inhibit the spores germination was already showed using human cells. The different monocyte subsets CD14⁺CD16⁻ and CD14⁺CD16⁺ react distinctly to A. fumigatus conidia either by controlling germination and secreting low levels of TNF or by producing high levels of inflammatory cytokines while not being able to suppress germination of conidia, respectively. These data indicate that the monocyte subsets may differ in their response to A. fumigatus infection depending on the cell phenotype that encounters the pathogen [143]. During experimental lung infection with A. fumigatus, inflammatory monocytes can differentiate into monocyte-derived dendritic cells and transport spores to lung-draining lymph nodes, thus making a link to acquired immunity and expansion of CD4-specific T cells [144]. Moreover, a differential regulation of expression of 1.827 genes was observed in vitro in human monocytes after their coincubation with A. fumigatus conidia [145]. Among these genes those related to host defense against fungal infection were upregulated between 2 and 6 hours of exposure to the fungus, such as IL-1, IL-8, CXCL2, CCL4, CCL3, and CCL20, coinciding with an increase in phagocytosis. Another study, using the same model of coincubation, showed a differential regulation of 602 genes with an upregulated expression of IL-8, CCL20, and CCL2 on monocytes after 3 hours of coincubation with A. fumigatus hyphae, in contrast to only 206 genes in response to resting conidia [146].

The importance of natural killer (NK) cells to control A. fumigatus infection was first described in neutropenic mice that received adoptive transfer of NK cells [147]. The authors observed a reduction in CCL2 expression in the lungs early during fungal infection, and when this protein was neutralized a greater mortality and fungal burden in lungs were observed. This neutralization was also accompanied by a reduction in NK cells recruitment into the lungs, suggesting an important role of these cells in the control of A. fumigatus infection. Similarly, early during A. fumigatus infection in neutropenic mice, NK cells were the main source of IFN- production, and when these cells were depleted a reduction in the level of this cytokine was observed, coupled to a higher fungal load in the lungs [148]. In addition, when the authors used adoptive transfer of NK cells from wild-type, but not from IFN-γ deficient mice, there was a greater fungal clearance from the lungs, indicating that NK cells function as a relevant source of IFN- for this fungal control (Figure 1). Furthermore, the importance of NK cells was also related to its in vitro capability to damage A. fumigatus hyphae, but not resting spores, especially when incubated with alveolar macrophages, resulting in 2–8-fold greater killing and a marked induction of CXCL9, CXCL10, and CXCL11 when compared to macrophages alone or macrophages incubated with IFN--deficient NK cells [148]. NK cells may also damage A. fumigatus by directly releasing soluble factors such as IFN- [149]. Taken together, these findings indicate that complex and multifactorial innate processes may act as the initial defense mechanisms to avoid A. fumigatus lung infection and disease establishment.

3.2. Acquired Immune Response

Innate immunity alone is able to control fungal infections especially at low doses; however, when the airway infections become frequent or high fungal burdens occur, acquired immunity is necessary to host protection [150]. Accordingly, the role of CD4 (including Th1, Th2, Th17 and regulatory) or CD8 T-cell responses during A. fumigatus spore exposure was already showed in experimental (mice) and in vitro assays using human cells. In these studies different T helper cell responses were observed depending on the fungal specific components to which T lymphocytes were exposed, thus inducing protective or harmful reactions; that is, fungal secreted proteins activated nonprotective (Th2) IL-4 secreting clones, glycolipids led to nonprotective (Th17) IL-17 activated response, and polysaccharides induced protective IFNγ, IL-17, or IL-10-clones besides GPI-anchored proteins (Gel1p and Crf1p) and proteases (Pep1p) leading to Th1/Treg protective reactions [151]. Therefore, Th1/Treg response plays a protective/regulatory role, whereas Th17 could have a protective or a harmful role depending on which fungal specific component this T helper cell subtype interacts with. However, Th2 cells seem to play a nonprotective role during A. fumigatus infection and are especially activated after interaction with fungal secreted proteins.

The predominance and contribution of Th2 cells (Figure 1) to disease progression were also observed in cystic fibrosis patients who develop ABPA [152, 153]. To note, individuals with cystic fibrosis present an overall risk of 4–15% to develop ABPA [153]. In fact, the dendritic cells of cystic fibrosis patients with ABPA present elevated expression of the costimulatory molecule OX40 ligand coupled to a lower secretion of TGF-β, a profile linked to a Th2-biased cell response which is not observed in cystic fibrosis patients without ABPA [152]. In an experimental murine model with repeated challenges using A. fumigatus conidia, especially after four exposures, there was a predominance of IgE, eosinophils, and IL-4, all are hallmarks of Th2 response [154], thus suggesting that the Th2 response predisposes to A. fumigatus infection. Moreover, Shreiner et al. demonstrated the importance of IL-4 and especially IL-10 in the generation of a Th2 response during an 8-week experimental chronic infection with this fungus, rather than acting as anti-inflammatory cytokine [155].

On the other hand, the protective role of Th1 response (Figure 1) during A. fumigatus infection was reinforced both in immunocompromised patients [156, 157] and in neutropenic mice due to its capability to neutralize Th2 cytokines [158]. In this context, Cenci et al. showed that when CD4 T cells produced IFN-γ in vitro and not IL-4, a protective acquired immunity was developed. This evidence was also clear when the animals infected with A. fumigatus were treated with IFN-γ and a lower mortality rate was observed when compared to the nontreated group. The importance of monocyte-derived dendritic cells to drive CD4 T cell differentiation during A. fumigatus infection was also observed. In the absence of dendritic cells there is a prevalence of Th17 over Th1 phenotype, together with the lost of T-bet expression in CD4 specific T cells, suggesting that monocyte-derived dendritic cells are important for the maintenance and development of protective Th1 cell response against the fungus. In addition, the predominance of Th1 response against A. fumigatus was also demonstrated in healthy individuals [159].

For many years, until the discovery of Th17 cell subtype [160], the occurrence and immunopathogenesis of fungal infections was attributed only for the traditional balance/imbalance between Th1 and Th2 responses [161–163]. However, in the last years different studies have shown a controversy role for Th17 response (Figure 1) during A. fumigatus infection. In mice experimentally infected with A. fumigatus or Candida albicans, the production of Th17 signatures cytokines, such as IL-23 and IL-17, may play a nonprotective role during fungal infection due to its ability to negatively regulate the development of Th1 response and to impair the in vitro neutrophil-mediated killing or the in vivo fungal clearance [164]. To reinforce the negative influence of Th17 cells on fungal control, these authors blocked in vivo the IL-23 and IL-17 cytokines and observed an increased resistance to both infections, as evaluated by the observation of a decreased fungal growth in the lungs. Despite the permissive role of Th2 response in the progression of A. fumigatus infection, the deleterious participation of Th17 cells was also observed in an experimental model of chronic infection in which the inflammatory reaction was characterized by eosinophilia and Th2 cell-associated cytokine profile coupled to IL-17 production, which persisted even after Th2 response, had begun to resolve [165]. These data indicated that Th17 could be as detrimental as Th2-biased response for host during A. fumigatus infection. In this study, after repeated challenges with fungus conidia, when an IL-17 knockout mice was used, the inflammation was attenuated and fungus clearance was enhanced. On the other hand, the protective role of IL-17 in the host defense against this fungus was also observed in another experimental model of A. fumigatus infection. In this case, the in vivo neutralization of this Th17-related cytokine early during infection resulted in an impaired pathogen clearance that led to an increased fungal pulmonary burden [112]. Therefore, the exact role of IL-17 in the A. fumigatus infection is still not totally clear yet and may depend on the host, time of infection, or even contact with fungal specific wall components [151].

The expansion of regulatory T cells (Tregs) (Figure 1) during fungal infections may constitute an important tool to avoid deleterious or exacerbated inflammation due to Th1 response or hypersensitivity reactions associated with Th2 responses [154]. Tregs may play a relevant role early in the A. fumigatus infection by modulating proinflammatory activities of polymorphonuclear leukocytes through contact-dependent or independent mechanisms such as IL-10 production [166]. Otherwise, later during A. fumigatus infection Tregs may work especially by inhibiting Th2 cell response and then preventing allergy to the fungus.

Besides CD4 T helper responses, it is know that CD8⁺ T cells may also mediate protective immunity against A. fumigatus infection, especially through recognition of HLA-A*0201 restricted fungal peptides [167]. Furthermore, dendritic cells may recognize fungal RNA by TLR3 and induce class I MHC restricted CD8 T-cell protective responses to A. fumigatus [122]. In addition, Templeton et al. observed increased IFN-γ producing CD8⁺ T cells in bronchoalveolar lavage fluid of mice repeatedly challenged with A. fumigatus conidia coupled to the maintenance of airway memory phenotype CD8⁺ T cells [168]. The maintenance of this CD8⁺ T cells in airways could be attributed to the specific characteristic of A. fumigatus conidia to germinate and persist in lungs, thus pointing to cytotoxic cells as another important mechanism for fungal control.

4. Concluding Remarks

In summary, this review showed that the control of A. fumigatus infection is associated with different and interconnected mechanisms dependent on the interplay between the pathogen virulence factors and the host immune competence. Recently it was showed that the immune response induced by Aspergillus spp. may be dependent on variations of the fungus strain that could present diverse virulence factors and therefore increased or reduced infectivity [169]. Even though, in general, the infection control may begin early during pathogen invasion when the fungus crosses physical or chemical natural barriers which, if disrupted, may lead to the pathogen recognition and activation of innate immunity receptors and cells like macrophages and neutrophils that, in turn, may initiate the acquired immunity events represented by CD4 or CD8 T-cell activations. In this context, a consensus among the authors that Th1-biased response is protective seems to exist, due to its ability to recruit other cells and restrain fungal growth, while the Th2 cell response is harmful especially to be associated with higher fungal burden at lungs or the occurrence of allergy. In addition, a controversy remains regarding the role of Th17 responses during A. fumigatus infection, while the cytotoxic activity of CD8 lymphocytes may be essential in some circumstances of intracellular pathogen. Overall, the regulation of leukocyte excess inflammation and avoidance of tissue damage directed to the elimination of A. fumigatus is related to Tregs activity. However, further studies must be conducted in order to better clarify how certain fungal compounds may activate or escape from the immune system as well as to provide tools for the development of novel therapeutic approaches to control this fungal lung infection.

Acknowledgments

The authors would like to thank Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP-2010/50878-4) for financial and technical support. The research leading to these results has also received support and funding from the Núcleo de Apoio à Pesquisa em Doenças Inflamatórias (NAPDIN) under Grant agreement no. 11.1.21625.01.0. Helioswilton Sales-Campos receives Ph.D. degree scholarship from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, 141050/2013-6).

References

A. C. Mayer, “Verschimmelung (mucedo) im lebenden korper,” Deutsches Arch Physiology, vol. 1, pp. 310–312, 1815.

J. H. Benett, “On the parasitic vegetable structures found growing in living animals,” Transactions of the Royal Society of Edinburgh, vol. 15, pp. 277–279, 1842.

R. Virchow, “Beiträge zur Lehre von den beim menschen vorkommenden pflanzlichen parasiten,” Archives für Pathologische Anatomie und Physiologie und für Klinische Medicin, vol. 9, no. 4, pp. 557–593, 1856.

L. Rénon, Etude Sur L’aspergillose Chez les Animaux et Chez L’homme, Masson et Cie, Paris, France, 1897.

G. Fresenius, Beitrage zur Mykologie, HL Bronner, Frankfurt, Germany, 1850.

N. E. Rankin, “Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy,” British Medical Journal, vol. 1, no. 4816, pp. 918–919, 1953.

M. L. Uffredi, G. Mangiapan, J. Cadranel, and G. Kac, “Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 22, no. 8, pp. 457–462, 2003.

D. W. Denning, “Invasive aspergillosis,” Clinical Infectious Diseases, vol. 26, no. 4, pp. 781–803, 1998.

J. P. Latge, “Aspergillus fumigatus and aspergillosis,” Clinical Microbiology Reviews, vol. 12, no. 2, pp. 310–350, 1999.

T. J. Walsh, E. J. Anaissie, D. W. Denning, et al., “Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America,” Clinical Infectious Diseases, vol. 46, no. 3, pp. 327–360, 2008.

K. A. Marr, M. Koudadoust, M. Black, and S. A. Balajee, “Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay,” Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 6, pp. 1240–1247, 2001.

G. Tronchin, J. P. Bouchara, G. Larcher, J. C. Lissitzky, and D. Chabasse, “Interaction between Aspergillus fumigatus and basement membrane laminin: binding and substrate degradation,” Biology of the Cell, vol. 77, no. 2, pp. 201–208, 1993.

H. Ema, K. Kitano, T. Suda, et al., “In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21) (q22;q22),” Blood, vol. 75, no. 2, pp. 350–356, 1990.

L. Pagano, M. Caira, A. Nosari, et al., “Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study—sorveglianza epidemiologica infezioni fungine nelle emopatie maligne,” Clinical Infectious Diseases, vol. 45, no. 9, pp. 1161–1170, 2007.

W. Meersseman, S. J. Vandecasteele, A. Wilmer, E. Verbeken, W. E. Peetermans, and E. Van Wijngaerdert, “Invasive aspergillosis in critically ill patients without malignancy,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 6, pp. 621–625, 2004.

A. Fourneret-Vivier, B. Lebeau, M. R. Mallaret, et al., “Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000–2002),” Journal of Hospital Infection, vol. 62, no. 1, pp. 22–28, 2006.

J. P. Latge, “Tasting the fungal cell wall,” Cellular Microbiology, vol. 12, no. 7, pp. 863–872, 2010.

R. Bhabhra and D. S. Askew, “Thermotolerance and virulence of Aspergillus fumigatus: role of the fungal nucleolus,” Medical Mycology, vol. 43, no. 1, pp. S87–S93, 2005.

J. C. Rhodes, “Aspergillus fumigatus: growth and virulence,” Medical Mycology, vol. 44, no. 1, pp. 77–81, 2006.

R. Bhabhra, M. D. Miley, E. Mylonakis, et al., “Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence,” Infection and Immunity, vol. 72, no. 8, pp. 4731–4740, 2004.

J. Wagener, B. Echtenacher, M. Rohde, et al., “The putative α-1,2-mannosyltransferase AfMnt1 of the opportunistic fungal pathogen Aspergillus fumigatus is required for cell wall stability and full virulence,” Eukaryotic Cell, vol. 7, no. 10, pp. 1661–1673, 2008.

X. Feng, K. Krishnan, D. L. Richie, et al., “HacA-independent functions of the ER stress sensor irea synergize with the canonical UPR to influence virulence traits in Aspergillus fumigatus,” PLoS Pathogens, vol. 7, no. 10, article e1002330, 2011.

T. Fontaine, C. Simenel, G. Dubreucq, et al., “Molecular organization of the alkali-insoluble fraction of Aspergillus fumigatus cell wall,” Journal of Biological Chemistry, vol. 275, no. 36, pp. 27594–27607, 2000.

J. P. Latge, I. Mouyna, F. Tekaia, A. Beauvais, J. P. Debeaupuis, and W. Nierman, “Specific molecular features in the organization and biosynthesis of the cell wall of Aspergillus fumigatus,” Medical Mycology, vol. 43, no. 1, pp. S15–S22, 2005.

J. S. Brown, A. Aufauvre-Brown, J. Brown, J. M. Jennings, H. Arst Jr., and D. W. Holden, “Signature-tagged and directed mutagenesis identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity,” Molecular Microbiology, vol. 36, no. 6, pp. 1371–1380, 2000.

K. Ishibashi, N. N. Miura, Y. Adachi, H. Tamura, S. Tanaka, and N. Ohno, “The solubilization and biological activities of Aspergillus β-(1 → 3)-D-glucan,” FEMS Immunology and Medical Microbiology, vol. 42, no. 2, pp. 155–166, 2004.

D. Maubon, S. Park, M. Tanguy, et al., “AGS3, an α(1—3)glucan synthase gene family member of Aspergillus fumigatus, modulates mycelium growth in the lung of experimentally infected mice,” Fungal Genetics and Biology, vol. 43, no. 5, pp. 366–375, 2006.

E. Mellado, A. Aufauvre-Brown, N. A. R. Gow, and D. W. Holden, “The Aspergillus fumigatus chsC and chsG genes encode class III chitin synthases with different functions,” Molecular Microbiology, vol. 20, no. 3, pp. 667–679, 1996.

T. Fontaine, C. Simenel, G. Dubreucq, et al., “Molecular organization of the alkali-insoluble fraction of Aspergillus fumigatus cell wall,” Journal of Biological Chemistry, vol. 275, no. 52, pp. 41528–41529, 2000.

P. S. Schmalhorst, S. Krappmann, W. Vervecken, et al., “Contribution of galactofuranose to the virulence of the opportunistic pathogen Aspergillus fumigatus,” Eukaryotic Cell, vol. 7, no. 8, pp. 1268–1277, 2008.

I. Mouyna, W. Morelle, M. Vai, et al., “Deletion of GEL2 encoding for a β(1–3)glucanosyltransferase affects morphogenesis and virulence in Aspergillus fumigatus,” Molecular Microbiology, vol. 56, no. 6, pp. 1675–1688, 2005.

H. Li, H. Zhou, Y. Luo, H. Ouyang, H. Hu, and C. Jin, “Glycosylphosphatidylinositol (GPI) anchor is required in Aspergillus fumigatus for morphogenesis and virulence,” Molecular Microbiology, vol. 64, no. 4, pp. 1014–1027, 2007.

J. Romano, G. Nimrod, N. Ben-Tal, et al., “Disruption of the Aspergillus fumigatus ECM33 homologue results in rapid conidial germination, antifungal resistance and hypervirulence,” Microbiology, vol. 152, no. 7, pp. 1919–1928, 2006.

K. B. Lengeler, R. C. Davidson, C. D'Souza, et al., “Signal transduction cascades regulating fungal development and virulence,” Microbiology and Molecular Biology Reviews, vol. 64, no. 4, pp. 746–785, 2000.

B. Liebmann, M. Muller, A. Braun, and A. A. Brakhage, “The cyclic AMP-dependent protein kinase A network regulates development and virulence in Aspergillus fumigatus,” Infection and Immunity, vol. 72, no. 9, pp. 5193–5203, 2004.

W. Zhao, J. C. Panepinto, J. R. Fortwendel, et al., “Deletion of the regulatory subunit of protein kinase A in Aspergillus fumigatus alters morphology, sensitivity to oxidative damage, and virulence,” Infection and Immunity, vol. 74, no. 8, pp. 4865–4874, 2006.

A. Gehrke, T. Heinekamp, I. D. Jacobsen, and A. A. Brakhage, “Heptahelical receptors GprC and GprD of Aspergillus fumigatus are essential regulators of colony growth, hyphal morphogenesis, and virulence,” Applied and Environmental Microbiology, vol. 76, no. 12, pp. 3989–3998, 2010.

P. R. Kraus and J. Heitman, “Coping with stress: calmodulin and calcineurin in model and pathogenic fungi,” Biochemical and Biophysical Research Communications, vol. 311, no. 4, pp. 1151–1157, 2003.

D. S. Fox and J. Heitman, “Good fungi gone bad: the corruption of calcineurin,” BioEssays, vol. 24, no. 10, pp. 894–903, 2002.

W. J. Steinbach, R. A. Cramer Jr., B. Z. Perfect, et al., “Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 8, pp. 2979–2981, 2007.

W. J. Steinbach, R. A. Cramer Jr., B. Z. Perfect, et al., “Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus,” Eukaryotic Cell, vol. 5, no. 7, pp. 1091–1103, 2006.

M. E. D. S. Ferreira, T. Heinekamp, A. Hartl, et al., “Functional characterization of the Aspergillus fumigatus calcineurin,” Fungal Genetics and Biology, vol. 44, no. 3, pp. 219–230, 2007.

R. A. Cramer Jr., B. Z. Perfect, N. Pinchai, et al., “Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus,” Eukaryotic Cell, vol. 7, no. 7, pp. 1085–1097, 2008.

F. M. Soriani, I. Malavazi, M. E. Da Silva Ferreira, et al., “Functional characterization of the Aspergillus fumigatus CRZ1 homologue, CrzA,” Molecular Microbiology, vol. 67, no. 6, pp. 1274–1291, 2008.

J. R. Fortwendel, P. R. Juvvadi, N. Pinchai, et al., “Differential effects of inhibiting chitin and 1,3-β-D-glucan synthesis in Ras and calcineurin mutants of Aspergillus fumigatus,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 2, pp. 476–482, 2009.

J. R. Fortwendel, P. R. Juvvadi, L. E. Rogg, et al., “Plasma membrane localization is required for RasA-mediated polarized morphogenesis and virulence of Aspergillus fumigatus,” Eukaryotic Cell, vol. 11, no. 8, pp. 966–977, 2012.

J. R. Fortwendel, W. Zhao, R. Bhabhra, et al., “A fungus-specific Ras homolog contributes to the hyphal growth and virulence of Aspergillus fumigatus,” Eukaryotic Cell, vol. 4, no. 12, pp. 1982–1989, 2005.

J. C. Panepinto, B. G. Oliver, J. R. Fortwendel, D. L. H. Smith, D. S. Askew, and J. C. Rhodes, “Deletion of the Aspergillus fumigatus gene encoding the Ras-related protein rhbA reduces virulence in a model of invasive pulmonary aspergillosis,” Infection and Immunity, vol. 71, no. 5, pp. 2819–2826, 2003.

S. Youngchim, R. Morris-Jones, R. J. Hay, and A. J. Hamilton, “Production of melanin by Aspergillus fumigatus,” Journal of Medical Microbiology, vol. 53, no. 3, pp. 175–181, 2004.

J. Schmaler-Ripcke, V. Sugareva, P. Gebhardt, et al., “Production of pyomelanin, a second type of melanin, via the tyrosine degradation pathway in Aspergillus fumigatus,” Applied and Environmental Microbiology, vol. 75, no. 2, pp. 493–503, 2009.

V. Sugareva, A. Hartl, M. Brock, et al., “Characterisation of the laccase-encoding gene abr2 of the dihydroxynaphthalene-like melanin gene cluster of Aspergillus fumigatus,” Archives of Microbiology, vol. 186, no. 5, pp. 345–355, 2006.

A. McDonagh, N. D. Fedorova, J. Crabtree, et al., “Sub-telomere directed gene expression during initiation of invasive aspergillosis,” PLoS Pathogens, vol. 4, no. 9, article e1000154, 2008.

C. O. Morton, J. J. Varga, A. Hornbach, et al., “The temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitro,” PLoS ONE, vol. 6, no. 1, article e16016, 2011.

B. Jahn, K. Langfelder, U. Schneider, C. Schindel, and A. A. Brakhage, “PKSP-dependent reduction of phagolysosome fusion and intracellular kill of Aspergillus fumigatus conidia by human monocyte-derived macrophages,” Cellular Microbiology, vol. 4, no. 12, pp. 793–803, 2002.

H. F. Tsai, Y. C. Chang, R. G. Washburn, M. H. Wheeler, and K. J. Kwon-Chung, “The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence,” Journal of Bacteriology, vol. 180, no. 12, pp. 3031–3038, 1998.

K. Langfelder, B. Jahn, H. Gehringer, A. Schmidt, G. Wanner, and A. A. Brakhage, “Identification of a polyketide synthase gene (pksP) of Aspergillus fumigatus involved in conidial pigment biosynthesis and virulence,” Medical Microbiology and Immunology, vol. 187, no. 2, pp. 79–89, 1998.

B. Jahn, F. Boukhallouk, J. Lotz, K. Langfelder, G. Wanner, and A. A. Brakhage, “Interaction of human phagocytes with pigmentless Aspergillus conidia,” Infection and Immunity, vol. 68, no. 6, pp. 3736–3739, 2000.

S. Paris, D. Wysong, J. P. Debeaupuis, et al., “Catalases of Aspergillus fumigatus,” Infection and Immunity, vol. 71, no. 6, pp. 3551–3562, 2003.

D. I. Tsitsigiannis, J. W. Bok, D. Andes, K. F. Nielsen, J. C. Frisvad, and N. P. Keller, “Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence,” Infection and Immunity, vol. 73, no. 8, pp. 4548–4559, 2005.

E. P. Reeves, K. Reiber, C. Neville, O. Scheibner, K. Kavanagh, and S. Doyle, “A nonribosomal peptide synthetase (Pes1) confers protection against oxidative stress in Aspergillus fumigatus,” FEBS Journal, vol. 273, no. 13, pp. 3038–3053, 2006.

D. E. Ejzykowicz, N. V. Solis, F. N. Gravelat, et al., “Role of Aspergillus fumigatus DvrA in host cell interactions and virulence,” Eukaryotic Cell, vol. 9, no. 10, pp. 1432–1440, 2010.

D. E. Ejzykowicz, M. M. Cunha, S. Rozental, et al., “The Aspergillus fumigatus transcription factor Ace2 governs pigment production, conidiation and virulence,” Molecular Microbiology, vol. 72, no. 1, pp. 155–169, 2009.

N. P. Keller, G. Turner, and J. W. Bennett, “Fungal secondary metabolism—from biochemistry to genomics,” Nature Reviews Microbiology, vol. 3, no. 12, pp. 937–947, 2005.

M. Rohlfs, M. Albert, N. P. Keller, and F. Kempken, “Secondary chemicals protect mould from fungivory,” Biology Letters, vol. 3, no. 5, pp. 523–525, 2007.

A. A. Brakhage and V. Schroeckh, “Fungal secondary metabolites—strategies to activate silent gene clusters,” Fungal Genetics and Biology, vol. 48, no. 1, pp. 15–22, 2011.

J. W. Bok and N. P. Keller, “LaeA, a regulator of secondary metabolism in Aspergillus spp,” Eukaryotic Cell, vol. 3, no. 2, pp. 527–535, 2004.

A. Hamahata, Y. Takata, T. Gomi, and M. Fujioka, “Probing the S-adenosylmethionine-binding site of rat guanidinoacetate methyltransferase: effect of site-directed mutagenesis of residues that are conserved across mammalian non-nucleic acid methyltransferases,” Biochemical Journal, vol. 317, part 1, pp. 141–145, 1996.

J. W. Bok, S. A. Balajee, K. A. Marr, et al., “LaeA, a regulator of morphogenetic fungal virulence factors,” Eukaryotic Cell, vol. 4, no. 9, pp. 1574–1582, 2005.

K. J. Kwon-Chung and J. A. Sugui, “What do we know about the role of gliotoxin in the pathobiology of Aspergillus fumigatus?” Medical Mycology, vol. 47, supplement 1, pp. S97–S103, 2009.

X. Li, M. Gao, X. Han, et al., “Disruption of the phospholipase D gene attenuates the virulence of Aspergillus fumigatus,” Infection and Immunity, vol. 80, no. 1, pp. 429–440, 2012.

J. T. Djordjevic, “Role of phospholipases in fungal fitness, pathogenicity, and drug development—lessons from cryptococcus neoformans,” Frontiers in Microbiology, vol. 1, p. 125, 2010.

S. Krappmann, E. M. Bignell, U. Reichard, T. Rogers, K. Haynes, and G. H. Braus, “The Aspergillus fumigatus transcriptional activator CpcA contributes significantly to the virulence of this fungal pathogen,” Molecular Microbiology, vol. 52, no. 3, pp. 785–799, 2004.

T. M. Dinamarco, R. S. Almeida, P. A. de Castro, et al., “Molecular characterization of the putative transcription factor SebA involved in virulence in Aspergillus fumigatus,” Eukaryotic Cell, vol. 11, no. 4, pp. 518–531, 2012.

A. J. Clutterbuck, “A mutational analysis of conidial development in Aspergillus nidulans,” Genetics, vol. 63, no. 2, pp. 317–327, 1969.

F. N. Gravelat, D. E. Ejzykowicz, L. Y. Chiang, et al., “Aspergillus fumigatus MedA governs adherence, host cell interactions and virulence,” Cellular Microbiology, vol. 12, no. 4, pp. 473–488, 2010.

C. B. Fleck, F. Schobel, and M. Brock, “Nutrient acquisition by pathogenic fungi: nutrient availability, pathway regulation, and differences in substrate utilization,” International Journal of Medical Microbiology, vol. 301, no. 5, pp. 400–407, 2011.

J. Behnsen, F. Lessing, S. Schindler, et al., “Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5,” Infection and Immunity, vol. 78, no. 8, pp. 3585–3594, 2010.

M. A. Moreno, O. Ibrahim-Granet, R. Vicentefranqueira, et al., “The regulation of zinc homeostasis by the ZafA transcriptional activator is essential for Aspergillus fumigatus virulence,” Molecular Microbiology, vol. 64, no. 5, pp. 1182–1197, 2007.

P. Canessa and L. F. Larrondo, “Environmental responses and the control of iron homeostasis in fungal systems,” Applied Microbiology and Biotechnology, vol. 97, no. 3, pp. 939–955, 2013.

D. Kornitzer, “Fungal mechanisms for host iron acquisition,” Current Opinion in Microbiology, vol. 12, no. 4, pp. 377–383, 2009.

H. Haas, “Iron—a key nexus in the virulence of Aspergillus fumigatus,” Frontiers in Microbiology, vol. 3, p. 28, 2012.

M. Schrettl, E. Bignell, C. Kragl, et al., “Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence,” Journal of Experimental Medicine, vol. 200, no. 9, pp. 1213–1219, 2004.

M. Schrettl, E. Bignell, C. Kragl, et al., “Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection,” PLoS Pathogens, vol. 3, no. 9, pp. 1195–1207, 2007.

A. H. Hissen, A. N. Wan, M. L. Warwas, L. J. Pinto, and M. M. Moore, “The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence,” Infection and Immunity, vol. 73, no. 9, pp. 5493–5503, 2005.

P. Hortschansky, M. Eisendle, Q. Al-Abdallah, et al., “Interaction of HapX with the CCAAT-binding complex—a novel mechanism of gene regulation by iron,” EMBO Journal, vol. 26, no. 13, pp. 3157–3168, 2007.

M. Schrettl, H. S. Kim, M. Eisendle, et al., “SreA-mediated iron regulation in Aspergillus fumigatus,” Molecular Microbiology, vol. 70, no. 1, pp. 27–43, 2008.

H. Liu, F. N. Gravelat, L. Y. Chiang, et al., “Aspergillus fumigatus AcuM regulates both iron acquisition and gluconeogenesis,” Molecular Microbiology, vol. 78, no. 4, pp. 1038–1054, 2010.

M. Blatzer, B. M. Barker, S. D. Willger, et al., “SREBP coordinates iron and ergosterol homeostasis to mediate triazole drug and hypoxia responses in the human fungal pathogen Aspergillus fumigatus,” PLoS Genetics, vol. 7, no. 12, article e1002374, 2011.

R. Jain, V. Valiante, N. Remme, et al., “The MAP kinase MpkA controls cell wall integrity, oxidative stress response, gliotoxin production and iron adaptation in Aspergillus fumigatus,” Molecular Microbiology, vol. 82, no. 1, pp. 39–53, 2011.

M. Schrettl, N. Beckmann, J. Varga, et al., “HapX-mediated adaption to iron starvation is crucial for virulence of Aspergillus fumigatus,” PLoS Pathogens, vol. 6, no. 9, article e01124, 2010.

D. Chung, H. Haas, and R. A. Cramer, “Coordination of hypoxia adaptation and iron homeostasis in human pathogenic fungi,” Frontiers in Microbiology, vol. 3, p. 381, 2012.

S. D. Willger, S. Puttikamonkul, K. H. Kim, et al., “A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus,” PLoS Pathogens, vol. 4, no. 11, article e1000200, 2008.

N. Grahl, T. M. Dinamarco, S. D. Willger, G. H. Goldman, and R. A. Cramer, “Aspergillus fumigatus mitochondrial electron transport chain mediates oxidative stress homeostasis, hypoxia responses and fungal pathogenesis,” Molecular Microbiology, vol. 84, no. 2, pp. 383–399, 2012.

P. D. Barnes and K. A. Marr, “Aspergillosis: spectrum of disease, diagnosis, and treatment,” Infectious Disease Clinics of North America, vol. 20, no. 3, pp. 545–561, 2006.

K. F. Hinson, A. J. Moon, and N. S. Plummer, “Broncho-pulmonary aspergillosis; a review and a report of eight new cases,” Thorax, vol. 7, no. 4, pp. 317–333, 1952.

R. G. Slavin, C. W. Bedrossian, P. S. Hutcheson, et al., “A pathologic study of allergic bronchopulmonary aspergillosis,” Journal of Allergy and Clinical Immunology, vol. 81, no. 4, pp. 718–725, 1988.

S. Paris, E. Boisvieux-Ulrich, B. Crestani, et al., “Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells,” Infection and Immunity, vol. 65, no. 4, pp. 1510–1514, 1997.

B. Chauhan, A. P. Knutsen, P. S. Hutcheson, R. G. Slavin, and C. J. Bellone, “T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis,” Journal of Clinical Investigation, vol. 97, no. 10, pp. 2324–2331, 1996.

A. P. Knutsen, P. S. Hutcheson, R. G. Slavin, and V. P. Kurup, “IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis,” Allergy, vol. 59, no. 2, pp. 198–203, 2004.

B. Addis, “Pulmonary mycotic disease—pulmonary aspergillosis,” in Spencer's Pathology of the Lung, H. PS, Ed., pp. 257–265, McGraw-Hill Professional, New York, NY, USA, 1996.

J. L. Saraceno, D. T. Phelps, T. J. Ferro, R. Futerfas, and D. B. Schwartz, “Chronic necrotizing pulmonary aspergillosis: approach to management,” Chest, vol. 112, no. 2, pp. 541–548, 1997.

S. Kawamura, S. Maesaki, K. Tomono, T. Tashiro, and S. Kohno, “Clinical evaluation of 61 patients with pulmonary aspergilloma,” Internal Medicine, vol. 39, no. 3, pp. 209–212, 2000.

A. O. Soubani and P. H. Chandrasekar, “The clinical spectrum of pulmonary aspergillosis,” Chest, vol. 121, no. 6, pp. 1988–1999, 2002.

W. B. Gefter, T. R. Weingrad, D. M. Epstein, R. H. Ochs, and W. T. Miller, “‘Semi-invasive’ pulmonary aspergillosis: a new look at the spectrum of Aspergillus infections of the lung,” Radiology, vol. 140, no. 2, pp. 313–321, 1981.

J. Mullins, R. Harvey, and A. Seaton, “Sources and incidence of airborne Aspergillus fumigatus (Fres),” Clinical Allergy, vol. 6, no. 3, pp. 209–217, 1976.

S. Husain, B. D. Alexander, P. Munoz, et al., “Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi,” Clinical Infectious Diseases, vol. 37, no. 2, pp. 221–229, 2003.

V. Aimanianda, J. Bayry, S. Bozza, et al., “Surface hydrophobin prevents immune recognition of airborne fungal spores,” Nature, vol. 460, no. 7259, pp. 1117–1121, 2009.

F. Botterel, K. Gross, O. Ibrahim-Granet, et al., “Phagocytosis of Aspergillus fumigatus conidia by primary nasal epithelial cells in vitro,” BMC Microbiology, vol. 8, article 97, 2008.

R. Amitani, G. Taylor, E. N. Elezis, et al., “Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium,” Infection and Immunity, vol. 63, no. 9, pp. 3266–3271, 1995.

C. Beisswenger, C. Hess, and R. Bals, “Aspergillus fumigatus conidia induce interferon-β signalling in respiratory epithelial cells,” European Respiratory Journal, vol. 39, no. 2, pp. 411–418, 2012.

S. S. Mambula, K. Sau, P. Henneke, D. T. Golenbock, and S. M. Levitz, “Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus,” Journal of Biological Chemistry, vol. 277, no. 42, pp. 39320–39326, 2002.

J. L. Werner, A. E. Metz, D. Horn, et al., “Requisite role for the dectin-1 β-glucan receptor in pulmonary defense against Aspergillus fumigatus,” Journal of Immunology, vol. 182, no. 8, pp. 4938–4946, 2009.

C. Y. Che, C. Li, A. Gao, et al., “Dectin-1 expression at early period of Aspergillus fumigatus infection in rat's corneal epithelium,” International Journal of Ophthalmology, vol. 6, no. 1, pp. 30–33, 2013.

M. G. Netea, A. Warris, J. W. M. Van der Meer, et al., “Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction,” Journal of Infectious Diseases, vol. 188, no. 2, pp. 320–326, 2003.

I. Rubino, A. Coste, D. Le Roy, et al., “Species-specific recognition of Aspergillus fumigatus by toll-like receptor 1 and toll-like receptor 6,” Journal of Infectious Diseases, vol. 205, no. 6, pp. 944–954, 2012.

S. Bellocchio, S. Moretti, K. Perruccio, et al., “TLRs govern neutrophil activity in aspergillosis,” Journal of Immunology, vol. 173, no. 12, pp. 7406–7415, 2004.

A. P. Moreira, K. A. Cavassani, U. B. Ismailoglu, et al., “The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A,” Journal of Clinical Investigation, vol. 121, no. 11, pp. 4420–4432, 2011.

J. E. Wang, A. Warris, E. A. Ellingsen, et al., “Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae,” Infection and Immunity, vol. 69, no. 4, pp. 2402–2406, 2001.

M. Dziembowska and J. Wlodarczyk, “MMP9: a novel function in synaptic plasticity,” International Journal of Biochemistry and Cell Biology, vol. 44, no. 5, pp. 709–713, 2012.

B. Bakowski and H. Tschesche, “Migration of polymorphonuclear leukocytes through human amnion membrane—A scanning electron microscopic study,” Biological Chemistry Hoppe Seyler, vol. 373, no. 7, pp. 529–546, 1992.

P. G. Gibson, P. A. B. Wark, J. L. Simpson, et al., “Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis,” European Respiratory Journal, vol. 21, no. 4, pp. 582–588, 2003.

A. Carvalho, A. De Luca, S. Bozza, et al., “TLR3 essentially promotes protective class I-restricted memory CD8⁺ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients,” Blood, vol. 119, no. 4, pp. 967–977, 2012.

Z. G. Ramirez-Ortiz, C. A. Specht, J. P. Wang, et al., “Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA,” Infection and Immunity, vol. 76, no. 5, pp. 2123–2129, 2008.

C. Bretz, G. Gersuk, S. Knoblaugh, et al., “MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus,” Infection and Immunity, vol. 76, no. 3, pp. 952–958, 2008.

S. E. Girardin, I. G. Boneca, J. Viala, et al., “Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection,” Journal of Biological Chemistry, vol. 278, no. 11, pp. 8869–8872, 2003.

Y. Ogura, D. K. Bonen, N. Inohara, et al., “A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease,” Nature, vol. 411, no. 6837, pp. 603–606, 2001.

B. Opitz, A. Puschel, B. Schmeck, et al., “Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae,” Journal of Biological Chemistry, vol. 279, no. 35, pp. 36426–36432, 2004.

K. Kobayashi, N. Inohara, L. D. Hernandez, et al., “RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems,” Nature, vol. 416, no. 6877, pp. 194–199, 2002.

Z. J. Xu, G. Q. Zhao, Q. Wang, et al., “Nucleotide oligomerization domain 2 contributes to the innate immune response in THCE cells stimulated by Aspergillus fumigatus conidia,” International Journal of Ophthalmology, vol. 5, no. 4, pp. 409–414, 2012.

Z. Z. Li, L. L. Tao, J. Zhang, H. J. Zhang, and J. M. Qu, “Role of NOD2 in regulating the immune response to Aspergillus fumigatus,” Inflammation Research, vol. 61, no. 6, pp. 643–648, 2012.

B. Philippe, O. Ibrahim-Granet, M. C. Prevost, et al., “Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates,” Infection and Immunity, vol. 71, no. 6, pp. 3034–3042, 2003.

O. Ibrahim-Granet, B. Philippe, H. Boleti, et al., “Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages,” Infection and Immunity, vol. 71, no. 2, pp. 891–903, 2003.

A. Schaffner, H. Douglas, and A. Braude, “Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes,” Journal of Clinical Investigation, vol. 69, no. 3, pp. 617–631, 1982.

A. McCormick, L. Heesemann, J. Wagener, et al., “NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus,” Microbes and Infection, vol. 12, no. 12-13, pp. 928–936, 2010.

S. Bruns, O. Kniemeyer, M. Hasenberg, et al., “Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA,” PLoS Pathogens, vol. 6, no. 4, article e1000873, 2010.

T. A. Fuchs, U. Abed, C. Goosmann, et al., “Novel cell death program leads to neutrophil extracellular traps,” Journal of Cell Biology, vol. 176, no. 2, pp. 231–241, 2007.

M. Bianchi, A. Hakkim, V. Brinkmann, et al., “Restoration of NET formation by gene therapy in CGD controls aspergillosis,” Blood, vol. 114, no. 13, pp. 2619–2622, 2009.

V. Brinkmann, U. Reichard, C. Goosmann, et al., “Neutrophil extracellular traps kill bacteria,” Science, vol. 303, no. 5663, pp. 1532–1535, 2004.

C. F. Urban, D. Ermert, M. Schmid, et al., “Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans,” PLoS Pathogens, vol. 5, no. 10, article e1000639, 2009.

M. Bianchi, M. J. Niemiec, U. Siler, C. F. Urban, and J. Reichenbach, “Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent,” Journal of Allergy and Clinical Immunology, vol. 127, no. 5, pp. 1243.e7–1252.e7, 2011.

M. M. Mircescu, L. Lipuma, N. Van Rooijen, E. G. Pamer, and T. M. Hohl, “Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection,” Journal of Infectious Diseases, vol. 200, no. 4, pp. 647–656, 2009.

J. A. Sugui, H. S. Kim, K. A. Zarember, et al., “Genes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophils,” PLoS ONE, vol. 3, no. 7, article e2655, 2008.

N. V. Serbina, M. Cherny, C. Shi, et al., “Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia,” Journal of Immunology, vol. 183, no. 4, pp. 2678–2687, 2009.

T. M. Hohl, A. Rivera, L. Lipuma, et al., “Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection,” Cell Host and Microbe, vol. 6, no. 5, pp. 470–481, 2009.

K. J. Cortez, C. A. Lyman, S. Kottilil, et al., “Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus,” Infection and Immunity, vol. 74, no. 4, pp. 2353–2365, 2006.

J. Loeffler, Z. Haddad, M. Bonin, et al., “Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatus,” Journal of Medical Microbiology, vol. 58, part 1, pp. 49–58, 2009.

B. E. Morrison, S. J. Park, J. M. Mooney, and B. Mehrad, “Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1862–1870, 2003.

S. J. Park, M. A. Hughes, M. Burdick, R. M. Strieter, and B. Mehrad, “Early NK cell-derived IFN-γ is essential to host defense in neutropenic invasive aspergillosis,” Journal of Immunology, vol. 182, no. 7, pp. 4306–4312, 2009.

M. Bouzani, M. Ok, A. McCormick, et al., “Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-γ release,” Journal of Immunology, vol. 187, no. 3, pp. 1369–1376, 2011.

P. C. Porter, L. Roberts, A. Fields, et al., “Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease,” Infection and Immunity, vol. 79, no. 11, pp. 4459–4471, 2011.

S. Bozza, C. Clavaud, G. Giovannini, et al., “Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination,” Journal of Immunology, vol. 183, no. 4, pp. 2407–2414, 2009.

J. L. Kreindler, C. Steele, N. Nguyen, et al., “Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4⁺ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis,” Journal of Clinical Investigation, vol. 120, no. 9, pp. 3242–3254, 2010.

D. A. Stevens, R. B. Moss, V. P. Kurup, et al., “Allergic bronchopulmonary aspergillosis in cystic fibrosis—state of the art: cystic fibrosis foundation consensus conference,” Clinical Infectious Diseases, vol. 37, no. 3, pp. S225–S264, 2003.

B. J. Murdock, A. B. Shreiner, R. A. McDonald, et al., “Coevolution of , , and responses during repeated pulmonary exposure to Aspergillus fumigatus conidia,” Infection and Immunity, vol. 79, no. 1, pp. 125–135, 2011.

A. B. Shreiner, B. J. Murdock, A. A. S. Akha, et al., “Repeated exposure to Aspergillus fumigatus conidia results in CD4⁺ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1/Th2/Th17 microenvironment that requires interleukin-4 (IL-4) and IL-10,” Infection and Immunity, vol. 80, no. 1, pp. 388–397, 2012.

K. Perruccio, A. Tosti, E. Burchielli, et al., “Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation,” Blood, vol. 106, no. 13, pp. 4397–4406, 2005.

O. Beck, M. S. Topp, U. Koehl, et al., “Generation of highly purified and functionally active human cells against Aspergillus fumigatus,” Blood, vol. 107, no. 6, pp. 2562–2569, 2006.

E. Cenci, S. Perito, K. H. Enssle, et al., “Th1 and Th2 cytokines in mice with invasive aspergillosis,” Infection and Immunity, vol. 65, no. 2, pp. 564–570, 1997.

N. Chaudhary, J. F. Staab, and K. A. Marr, “Healthy human T-cell responses to Aspergillus fumigatus antigens,” PLoS ONE, vol. 5, no. 2, article e9036, 2010.

C. L. Langrish, Y. Chen, W. M. Blumenschein, et al., “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005.

A. Kunkl, L. Mortara, M. T. Valle, et al., “Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons,” Journal of Infectious Diseases, vol. 178, no. 2, pp. 488–496, 1998.

J. E. Leigh, C. Steele, F. L. Wormley Jr., et al., “Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 19, no. 4, pp. 373–380, 1998.

L. J. Kobrynski, L. Tanimune, L. Kilpatrick, D. E. Campbell, and S. D. Douglas, “Production of T-helper cell subsets and cytokines by lymphocytes from patients with chronic mucocutaneous candidiasis,” Clinical and Diagnostic Laboratory Immunology, vol. 3, no. 6, pp. 740–745, 1996.

T. Zelante, A. de Luca, P. Bonifazi, et al., “IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance,” European Journal of Immunology, vol. 37, no. 10, pp. 2695–2706, 2007.

A. B. Shreiner, B. J. Murdock, A. A. S. Akha, et al., “Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia,” Infection and Immunity, vol. 80, no. 4, pp. 1424–1436, 2012.

C. Montagnoli, F. Fallarino, R. Gaziano, et al., “Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism,” Journal of Immunology, vol. 176, no. 3, pp. 1712–1723, 2006.

Z. Sun, P. Zhu, L. Li, Z. Wan, Z. Zhao, and R. Li, “Adoptive immunity mediated by HLA-A∗0201 restricted Asp f16 peptides-specific CD8⁺ T cells against Aspergillus fumigatus infection,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 31, no. 11, pp. 3089–3096, 2012.

S. P. Templeton, A. D. Buskirk, B. Law, B. J. Green, and D. H. Beezhold, “Role of germination in Murine airway CD8⁺ T-cell responses to Aspergillus conidia,” PLoS ONE, vol. 6, no. 4, article e18777, 2011.

L. Rizzetto, G. Giovannini, M. Bromley, P. Bowyer, L. Romani, and D. Cavalieri, “Strain dependent variation of immune responses to A. fumigatus: definition of pathogenic species,” PLoS One, vol. 8, no. 2, article e56651, 2013.